Skip to main navigation menu Skip to main content Skip to site footer

Metabolic syndrome and complicated cholecystitis in adult women

Síndrome Metabólico y colecistitis complicada en mujeres adultas





Section
Research Articles

How to Cite
Díaz-Rosales, J. de D., Alcocer-Moreno, J. A., & Enríquez-Domíguez, L. (2016). Metabolic syndrome and complicated cholecystitis in adult women. Archivos De Medicina (Manizales), 16(2), 304-311. https://doi.org/10.30554/archmed.16.2.1734.2016
Download Citation

Dimensions
PlumX

How to Cite

Díaz-Rosales, J. de D., Alcocer-Moreno, J. A., & Enríquez-Domíguez, L. (2016). Metabolic syndrome and complicated cholecystitis in adult women. Archivos De Medicina (Manizales), 16(2), 304-311. https://doi.org/10.30554/archmed.16.2.1734.2016

Download Citation

Juan Antonio Alcocer-Moreno
Lenin Enríquez-Domíguez

Juan de Dios Díaz-Rosales,

General Surgeon. Surgery Service - Hospital General de Zona No. 35 / Instituto Mexicano del Seguro Social

Assistan Professor. Medical Sciences Department - Universidad Autónoma de Ciudad Juárez


Juan Antonio Alcocer-Moreno,

Cirujano General

Departamento de Cirugía - Hospital General Regional No. 66 / Instituto Mexicano del Seguro Social


Lenin Enríquez-Domíguez,

Cirujano General

Departamento de Cirugía - Hospital General de Zona No. 6 / Instituto Mexicano del Seguro Social 


Most read articles by the same author(s)

Objective: observe the prevalence of metabolic syndrome in patients with cholecystitis and analyze the relation with its severity. Materials and Methods: cross-sectional study in female patients with acute cholecystitis. Divided into two groups: group I - patients with acute cholecystitis without any other complication and, group II - patients with acute cholecystitis with any complication as: mucocele, empyema, choledocolithiasis, cholangitis, biliary pancreatitis, necrosis and, perforation. Variables measured were: weight, body mass index, waist, blood pressure, blood glucose and lipids levels, type 2 diabetes, arterial hypertension, dyslipidemia, and metabolic syndrome. Results: of 204 patients studied, 80 (39,2%) patients were complicated. There were statistical differences between groups in waist (98,9 cm vs 103,4 cm; p=0,04), patients with risk tryglicerides level (≥150 mg/dL) (41,9% vs 75%; p=0,001), and presence of metabolic syndrome (46,8% vs 67,5%; p=0,004). However, when adjusted logistic regression were realized, just risk tryglicerides level (≥150 mg/dL) were found as real risk factor (OR 4,058, IC 95% 1,870-8,807; p=0,000) for complicated cholecystitis group. Conclusion: neither metabolic syndrome nor waist circumference appear as risk factors for complicated cholecystitis, however, if the patients present tryglicerides level ≥150 mg/dL, the risk for complication increases significantly.

Article visits | PDF visits


Downloads

Download data is not yet available.
  1. Abraham S, Rivero HG, Erlikh I V, Griffith LF, Kondamudi VK. Surgical and nonsurgical management of gallstones. Am Fam Physician. 2014;89(10):795-802.
  2. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology. 1999;117(3):632-639.
  3. Méndez-Sánchez N, Jessurun J, Ponciano-Rodríguez G, Alonso-de-Ruiz P, Uribe M, Hernández-Avila M. Prevalence of gallstone disease in Mexico. A necropsy study. Dig Dis Sci. 1993;38(4):680-683.
  4. Shabanzadeh DM, Sørensen LT, Jørgensen T. Determinants for gallstone formation - a new data cohort study and a systematic review with meta-analysis. Scand J Gastroenterol. mayo 2016:In Press.
  5. Lin I-C, Yang Y-W, Wu M-F, et al. The association of metabolic syndrome and its factors with gallstone disease. BMC Fam Pract. 2014;15:138.
  6. Aguilar-Salinas CA, Rojas R, Gómez-Pérez FJ, et al. Analysis of the agreement between the World Health Organization criteria and the National Cholesterol Education Program-III definition of the metabolic syndrome: results from a population-based survey. Diabetes Care. 2003;26(5):1635.
  7. Díaz-Rosales J de D, Enríquez-Domínguez L, Díaz-Torres B. Factores de riesgo para hígado graso no alcohólico en pacientes con colelitiasis sintomática. Arch Med. 2016;16(1):98-108.
  8. Grundy SM. Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am J Clin Nutr. 2004;80(1):1-2.
  9. Rosales Ricardo Y. [Anthropometry in the diagnosis of obese patients: a review]. Nutr Hosp. 2012;27(6):1803-1809.
  10. Campos-Nonato I, Hernández-Barrera L, Rojas-Martínez R, Pedroza A, Medina-García C, Barquera-Cervera S. Hipertensión arterial: prevalencia, diagnóstico oportuno, control y tendencias en adultos mexicanos. Salud Publica Mex. 2013;55:S144-S150.
  11. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35(Suppl 1):S64-S71.
  12. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
  13. Wittenburg H. Hereditary liver disease: gallstones. Best Pract Res Clin Gastroenterol. 2010;24(5):747-756.
  14. Méndez-Sánchez N, Chavez-Tapia NC, Motola-Kuba D, et al. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol. 2005;11(11):1653-1657.
  15. Díaz-Rosales J de D, Enríquez-Domínguez L, Alcocer-Moreno JA, Romo-Martínez JE, Díaz-Torres B. Association of central obesity and severity in cholelithiasis during cholecystectomy in adult women. World J Med Med Sci Res. 2015;3(1):4-6.
  16. Tsai C-J, Leitzmann MF, Willett WC, Giovannucci EL. Central adiposity, regional fat distribution, and the risk of cholecystectomy in women. Gut. 2006;55(5):708-714.
  17. Tsai C-J. Steatocholecystitis and fatty gallbladder disease. Dig Dis Sci. 2009;54(9):1857-1863.
  18. Jeong SU, Lee SK. [Obesity and gallbladder diseases]. Korean J Gastroenterol. 2012;59(1):27-34.
  19. Cheng L, Luo Z, Xiang K, et al. Clinical significance of serum triglyceride elevation at early stage of acute biliary pancreatitis. BMC Gastroenterol. 2015;15:19.
  20. Liu Y-Y, Yeh C-N, Lee H-L, Chu P-H, Jan Y-Y, Chen M-F. Laparoscopic Cholecystectomy for Gallbladder Disease in Patients with Severe Cardiovascular Disease. World J Surg. 2009;33(8):1720-1726.
  21. Gaus O V, Akhmedov VA. [Dynamic of clinical, laboratory and sonographic parameters after successful litholitic therapy at patients with gallstone disease in association with metabolic syndrome]. Exp Clin Gastroenterol. 2015;(7):18-23.